As of 2025-12-15, the Relative Valuation of Pacira Biosciences Inc (PCRX) is 14.03 USD. This relative valuation is based on P/E multiples. With the latest stock price at 26.29 USD, the upside of Pacira Biosciences Inc based on Relative Valuation is -46.6%.
The range of the Relative Valuation is 11.43 - 18.48 USD.
| Range | Selected | |
| Trailing P/E multiples | 25.7x - 30.6x | 28.4x |
| Forward P/E multiples | 22.9x - 37.1x | 27.8x |
| Fair Price | 11.43 - 18.48 | 14.03 |
| Upside | -56.5% - -29.7% | -46.6% |
| Date | P/E |
| 2025-12-12 | 52.76 |
| 2025-12-11 | 51.63 |
| 2025-12-10 | 50.53 |
| 2025-12-09 | 49.71 |
| 2025-12-08 | 49.00 |
| 2025-12-05 | 48.14 |
| 2025-12-04 | 48.12 |
| 2025-12-03 | 48.54 |
| 2025-12-02 | 48.30 |
| 2025-12-01 | 47.56 |
| 2025-11-28 | 47.30 |
| 2025-11-26 | 47.78 |
| 2025-11-25 | 46.50 |
| 2025-11-24 | 46.48 |
| 2025-11-21 | 46.25 |
| 2025-11-20 | 45.75 |
| 2025-11-19 | 48.82 |
| 2025-11-18 | 48.94 |
| 2025-11-17 | 47.92 |
| 2025-11-14 | 47.72 |
| 2025-11-13 | 47.40 |
| 2025-11-12 | 47.88 |
| 2025-11-11 | 48.40 |
| 2025-11-10 | 46.29 |
| 2025-11-07 | 44.25 |
| 2025-11-06 | 42.34 |
| 2025-11-05 | 43.85 |
| 2025-11-04 | 45.03 |
| 2025-11-03 | 44.53 |
| 2025-10-31 | 42.90 |
| 2025-10-30 | 42.68 |
| 2025-10-29 | 42.16 |
| 2025-10-28 | 42.86 |
| 2025-10-27 | 42.80 |
| 2025-10-24 | 43.63 |
| 2025-10-23 | 43.47 |
| 2025-10-22 | 43.12 |
| 2025-10-21 | 44.19 |
| 2025-10-20 | 46.19 |
| 2025-10-17 | 45.89 |
| 2025-10-16 | 45.69 |
| 2025-10-15 | 47.06 |
| 2025-10-14 | 45.61 |
| 2025-10-13 | 44.67 |
| 2025-10-10 | 44.85 |
| 2025-10-09 | 46.27 |
| 2025-10-08 | 46.98 |
| 2025-10-07 | 47.40 |
| 2025-10-06 | 47.90 |
| 2025-10-03 | 49.85 |